Article (Scientific journals)
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
Baron, Frédéric; Storb, R.; Storer, B. E. et al.
2006In Journal of Clinical Oncology, 24 (25), p. 4150-4157
Peer Reviewed verified by ORBi
 

Files


Full Text
2ndHCTlJCO06.pdf
Publisher postprint (340.96 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Purpose Several studies have investigated the feasibility of allogeneic hematopoietic cell transplantations (HCTs) after reduced-intensity conditioning in patients who experienced relapse after myeloablative HCT. Although most studies showed relatively low nonrelapse mortality (NRM) rates and encouraging short-term results, it has yet to be defined which patients would benefit most from these approaches. Patients and Methods We analyzed data from 147 patients with hematologic malignancies who experienced treatment failure with conventional autologous (n = 135), allogeneic (n = 10), or syngeneic (n = 2) HCT and were treated with HLA-matched related (n = 62) or unrelated (n = 85) grafts after conditioning with 2 Gy of total-body irradiation with or without fludarabine. Results Three-year probabilities of NRM, relapse, and overall survival were 32%, 48%, and 27%, respectively, for related recipients, and 28%, 44%, and 44%, respectively, for unrelated recipients. The best outcomes were observed in patients with non-Hodgkin's lymphoma, whereas patients with multiple myeloma and Hodgkin's disease had worse outcomes as a result of high incidences of relapse and progression. Being in partial remission (PR) or complete remission (CR) at HCT (P = .002) and developing chronic graft-versus-host disease (GVHD; P = .03) resulted in lower risks of relapse and progression. Factors associated with better overall survival were PR or CR (P = .01) and lack of comorbidity (P = .03) at HCT and absence of acute GVHD after HCT (P = .06). Conclusion Encouraging outcomes were seen with allogeneic HCT after nonmyeloablative conditioning in selected patients who had experienced relapse after a high-dose HCT, particularly in patients with non-Hodgkin's lymphoma. Results with unrelated grafts were comparable with results with related grafts.
Disciplines :
Oncology
Author, co-author :
Baron, Frédéric  ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie
Storb, R.
Storer, B. E.
Maris, M. B.
Niederwieser, D.
Shizuru, J. A.
Chauncey, T. R.
Bruno, B.
Forman, S. J.
McSweeney, P. A.
Maziarz, R. T.
Pulsipher, M. A.
Agura, E. D.
Wade, J.
Sorror, M.
Maloney, D. G.
Sandmaier, B. M.
More authors (7 more) Less
Language :
English
Title :
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
Publication date :
01 September 2006
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
Amer Soc Clinical Oncology, Alexandria, U.S. Virgin Islands
Volume :
24
Issue :
25
Pages :
4150-4157
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 November 2011

Statistics


Number of views
29 (2 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
93
Scopus citations®
without self-citations
65
OpenCitations
 
87

Bibliography


Similar publications



Contact ORBi